Lamark Biotech’s Bold Bet on Thermostable Insulin Could Transform Diabetes Care in India and Beyond
In a major win for healthcare innovation in India, Lamark Biotech, an Ahmedabad-based biopharma startup, has raised Rs 6.5 crore in a pre-Series A funding round led by IAN Group, including IAN Alpha Fund powered by BioAngels, and a group of top angel investors with deep expertise in…
